Other
Dental Caries
12
Pipeline Programs↗
8
Active Trials↗
4
Companies Involved↗
Dental Caries is an emerging landscape with 12 programs across 4 companies. The most active players are GSK, Dexcel Pharma Technologies Ltd., WestVac Biopharma Co., Ltd.. 5 therapies are approved with 1 more in late-stage development.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical2
Phase 1
No programs
Phase 24
Analysis
Trial Status
22
clinical trials
Completed12 · 55%
Not yet recruiting3 · 14%
Active, not recruiting3 · 14%
Unknown status2 · 9%
Recruiting2 · 9%
Clinical Trials
Trial Activity
22 trials
Effect of Ozone Therapy on the Remineralization of Initial Caries Lesions in Children: A Randomized Controlled Clinical Trial
Recruiting·—·Preclinical·NCT07671651·80 enrolled
Clinical Outcomes of Prefabricated Zirconia and Bioflx Crowns for Restoring Primary Maxillary Anterior Teeth: A Randomized Controlled Trial
Active, not recruiting·HHue University of Medicine and Pharmacy·Preclinical·NCT07691905·120 enrolled
Prevention of Dental Caries Lesions With Fluoride Varnish in Erupting First Permanent Molars
Completed·—·Phase 4·NCT02592278·180 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)